Comparison of DNA Changes in the Genomes of Thyroid Hyperplasia, Papillary Thyroid Carcinoma, and Healthy Tissues Using Random Amplified Polymorphic DNA Polymerase Chain Reaction

Document Type : Original Article (s)

Authors

1 Associate Professor, Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Resident, Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Associate Professor, Department of Biology, School of Science, University of Isfahan, Iran

Abstract

Background: Thyroid carcinoma is the most common endocrine cancer. There are several methods for determining the mutation of genes, one of them is random amplified polymorphic DNA polymerase chain reaction (RAPD-PCR). This study aimed to compare DNA changes in the genome of thyroid hyperplasia, thyroid papillary carcinoma, and healthy tissues using RAPD-PCR.Methods: In this case-control study, 49 patients with papillary carcinoma and thyroid hyperplasia which had normal, hyperplasia, and papillary carcinoma tissues of the thyroid gland were randomly selected. Then, the primer pattern of the sequence 5'-AAGAGCCCGT-3' containing 10 pairs base was evaluated and compared between the tissues.Findings: The prevalence of 370-bp pair base band observed in normal, hyperplasia, and pylori thyroid carcinoma tissues was 6.1, 53.1, and 89.8 percent, respectively, and there was a significant difference between the three tissue types (P < 0.001). There was also a significant difference between normal tissue with hyperplasia and papillary carcinoma of the thyroid and between hyperplasia with thyroid carcinoma in this regard (P < 0.050).Conclusion: It seems that using RAPD-PCR is a suitable method for the detection and differentiation of normal, hyperplasia, and papillary thyroid carcinoma cells. Bat notice to the limitation of the study, more investigation in this field is recommended.

Keywords

References

  1. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993; 328(8): 553-9.
  2. Cai LL, Liu GY, Tzeng CM. Genome-wide DNA methylation profiling and its involved molecular pathways from one individual with thyroid malignant/benign tumor and hyperplasia: A case report. Medicine (Baltimore) 2016; 95(35): e4695.
  3. Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell 2012; 150(1): 12-27.
  4. Atienzar FA, Jha AN. The random amplified polymorphic DNA (RAPD) assay and related techniques applied to genotoxicity and carcinogenesis studies: A critical review. Mutat Res 2006; 613(2-3): 76-102.
  5. Malkhosyan S, Yasuda J, Soto JL, Sekiya T, Yokota J, Perucho M. Molecular karyotype (amplotype) of metastatic colorectal cancer by unbiased arbitrarily primed PCR DNA fingerprinting. Proc Natl Acad Sci USA 1998; 95(17): 10170-5.
  6. Xian ZH, Cong WM, Zhang SH, Wu MC. Genetic alterations of hepatocellular carcinoma by random amplified polymorphic DNA analysis and cloning sequencing of tumor differential DNA fragment. World J Gastroenterol 2005; 11(26): 4102-7.
  7. Ibrahim MA, Saleh N, Mousawy KM, Al-Hmoud N, Archoukieh E, Haithum W. Al-Obaide HW, et al. Molecular analysis of RAPD-PCR genomic patterns in age related acute myeloid leukemia. Trends Med Res 2009; 4(3): 35-41.
  8. El-Far M, Abol-Enein H, Zakaria A, El-Gedamy M. Detection of genomic instability in renal cancer by random amplified polymorphic DNA analysis from urine sample as a non-invasive method: Potential use in diagnosis. Cancer Sci Res Open Access 2013; 1(1): 7.
  9. Wreesmann VB, Ghossein RA, Patel SG, Harris CP, Schnaser EA, Shaha AR, et al. Genome-wide appraisal of thyroid cancer progression. Am J Pathol 2002; 161(5): 1549-56.
  10. Saxena S, Verma J, Shikha, Raj Modi D. RAPD-PCR and 16S rDNA phylogenetic analysis of alkaline protease producing bacteria isolated from soil of India: Identification and detection of genetic variability. Genet Eng Biotechnol J 2014; 12(1): 27-35.
  11. Talebi A, Daneshbakhtyiar S, Meshkat M, Meshkat M. Comparison of DNA instability in adenoma and adenocarcinoma in patients with colorectal cancer, using random amplified polymorphic DNA polymerase chain reaction (RAPD-PCR). J Isfahan Med Sch 2017; 35(432): 609-14. [In Persian].
  12. Luo L, Li B, Pretlow TP. DNA alterations in human aberrant crypt foci and colon cancers by random primed polymerase chain reaction. Cancer Res 2003; 63(19): 6166-9.
  13. Ismaeel HM. Biotechnology: Identification of genomic markers By RAPD-PCR primers in Iraq breast cancer patients. Iraqi J Sci 2013; 54(1): 97-104.
  14. Rowe LR, Bentz BG, Bentz JS. Detection of BRAF V600E activating mutation in papillary thyroid carcinoma using PCR with allele-specific fluorescent probe melting curve analysis. J Clin Pathol 2007; 60(11): 1211-5.
  15. Jabbar RN. Histopathological and molecular analysis of thyroid papillary and medullary carcinoma in a samples of Iraqi patients. Iraqi Journal of Cancer and Medical Genetics 2019; 5(1): 22-7.
Journal of Isfahan Medical School
Volume 37, Issue 514 - Serial Number 514
January and February 2019
Pages 55-59

Files

History

  • Receive Date: 07 December 2018
  • Revise Date:
  • Accept Date: 06 April 2022

Share

How to cite

Statistics